19-51341200-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001163922.3(VSIG10L):c.848G>A(p.Arg283Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000194 in 1,544,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001163922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG10L | NM_001163922.3 | c.848G>A | p.Arg283Gln | missense_variant | 2/10 | ENST00000335624.5 | NP_001157394.1 | |
VSIG10L-AS1 | NR_186316.1 | n.807+26C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG10L | ENST00000335624.5 | c.848G>A | p.Arg283Gln | missense_variant | 2/10 | 5 | NM_001163922.3 | ENSP00000335623.3 | ||
VSIG10L-AS1 | ENST00000594311.1 | n.132+26C>T | intron_variant | 5 | ||||||
VSIG10L-AS1 | ENST00000601148.5 | n.132+26C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152096Hom.: 0 Cov.: 32
GnomAD4 exome AF: 7.18e-7 AC: 1AN: 1392478Hom.: 0 Cov.: 30 AF XY: 0.00000146 AC XY: 1AN XY: 686696
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.848G>A (p.R283Q) alteration is located in exon 2 (coding exon 2) of the VSIG10L gene. This alteration results from a G to A substitution at nucleotide position 848, causing the arginine (R) at amino acid position 283 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at